Effects of alteplase on survival after ischaemic stroke (IST-3): 3 year follow-up of a randomised, controlled, open-label trial.
Berge E, Cohen G, Roaldsen MB, Lundström E, Isaksson E, Rudberg AS, Slot KB, Forbes J, Smith J, Drever J, Wardlaw JM, Lindley RI, Sandercock PA, Whiteley WN; IST-3 Collaborative Group.
Berge E, et al. Among authors: lindley ri.
Lancet Neurol. 2016 Sep;15(10):1028-34. doi: 10.1016/S1474-4422(16)30139-9. Epub 2016 Jul 20.
Lancet Neurol. 2016.
PMID: 27450474
Clinical Trial.